We identified that miRNA hsa-miR-224-5p targeted gene MAPKAPK2, lncRNA LINC00665 regulated miRNA hsa-miR-224-5p in CHD patients, and hsa-miR-224-5p was shared between LINC00665 and MAPKAPK2. Here, MAPKAPK2 is linked to coronary artery disorder.